Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 2006

View Archived Issues

Nalmefene shows promise in treating pathological gambling / News in Context

NXY-059 appears to reduce disability in ischemic stroke patients

LRH-1 activation: Potential efficacy as a treatment for atherosclerosis

New localized radiotherapeutic for prostate cancer

Capsaicin patch reduces pain in HIV-associated distal sensory polyneuropathy

GCPII inhibitor targeted for neuroprotection and prostate cancer

Neurochem completes rolling NDA for Fibrillex in AA amyloidosis

Phase I study of lemuteporfin in BPH fails to meet primary efficacy objective

Santen updates status of ophthalmic programs

ProMetic BioSciences cleared for Canadian phase Ib/II study of PBI-1402

Ranbaxy and CIH establish joint venture for antiretrovirals in South Africa

Eltrombopag begins phase III trials for ITP

Avant's typhoid fever vaccine Ty-800 studied in new phase I/II trial

BioXell and Lay Line Genomics sign agreement for MNAC13

European COMP recommends orphan drug designation for 1D09C3

Orthokine approved in E.U.

Glenmark discovers new drug targeting obesity

Retapamulin NDA under FDA review

Pfizer looks to value drivers to grow business

Prophylactic and therapeutic efficacy of targeting TLR9 for HSV-2

Recent Incyte patent describes new therapeutic agents for HIV infection

New agents for endocrine-related disorders imparted in recent patent literature

Orphan drug designation for TRX-4 in type 1 diabetes

Phase Ib trial investigates AP-23573 plus doxorubicin for cancer

MB-07803 studied in phase I for type 2 diabetes

New therapeutic agents described for cardiovascular disorders

Japanese phase II trial for gaboxadol

Ambrisentan use in PAH patients who discontinue other ERA therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...